Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 09:33 am Purchase | 2022-12-31 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 2,694,101 8.080% | 76,153 (+2.91%) | Filing History |
| 2022-09-08 1:19 pm Purchase | 2022-09-06 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,637,232 28.800% | 513,660 (+5.63%) | Filing History |
| 2022-05-13 4:31 pm Purchase | 2022-05-03 | 13G | HilleVax, Inc. HLVX | Lightspeed Venture Partners Select IV L.P. | 1,913,432 5.700% | 1,913,432 (New Position) | Filing History |
| 2022-05-13 4:31 pm Purchase | 2022-05-03 | 13G | HilleVax, Inc. HLVX | Abingworth LLP | 1,838,486 5.500% | 1,838,486 (New Position) | Filing History |
| 2022-05-09 06:08 am Purchase | 2022-04-28 | 13D | HilleVax, Inc. HLVX | Takeda Pharmaceutical Company Limited | 6,724,000 17.100% | 6,724,000 (New Position) | Filing History |
| 2022-05-06 4:15 pm Purchase | 2022-04-28 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,123,572 27.300% | 9,123,572 (New Position) | Filing History |
| 2022-05-03 5:11 pm Purchase | 2022-05-03 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 2,617,948 7.830% | 2,617,948 (New Position) | Filing History |